Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02889861
Title IMCgp100-401 Rollover Study
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Immunocore Ltd
Indications

melanoma

Therapies

Tebentafusp

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.